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Abstract
A possible role of hepatocyte nuclear factor 1 (HNF1)
or HNF3, a predominant trans-acting factors of
hepatic or pancreatic β-cells, was examined on the
tissue specific interdependent expression of gluco-
kinase (GK) in liver, H4IIE, HepG2, HIT-T15 and MIN6
cell line. The tissues or cell lines known to express
GK showed abundant levels of HNF1 and HNF3
mRNA as observed in liver, H4IIE, HepG2, HIT-T15
and MIN6 cells, whereas they were not detected in
brain, heart, NIH 3T3, HeLa cells. The promoter of
glucokinase contains several HNF3 consensus sequ-
ences and are well conserved in human, mouse and
rat. Transfection of the glucokinase promotor linked
with luciferase reporter to liver or pancreatic β cell
lines showed high interacting activities with HNF1
and HNF3, whereas minimal activities were detect-
ed in the cells expressing very low levels of HNFs.
The binding of HNF1 or HNF3 to the GK promoter
genes was confirmed by electrophoretic mobility shift
assay (EMSA). From these data, we propose that the
expression of HNF1 and/or HNF3 may, in part, con-
tribute to the tissue specific expression of GK
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Introduction
Tissue specific expression of specific subsets of genes
requires tightly controlled interplay of trans-acting factors.
For these phenomena, general or ubiquitous factors as
well as specific transcription factors are required for the
initiation and maintenance. Recently, many trans-acting
factors have been discovered acting on the liver or
pancreas specific genes. Of these, HNFs are one of the
trans-acting factors responsible for the expression of
liver or pancreatic β-cell specific genes (De Simone et
al., 1991; Tronche et al., 1997; Stoffel et al., 1997; Duncan
et al., 1998). HNF1 is a homeodomain protein that plays
a key role in the liver-specific expression of many genes
during differentiation and development (Miura et al.,
1993). HNF1 is required for the expression of GLUT2
and other liver-specific genes such as albumin, α1-anti-
trypsin, and fibrinogen (Wang et al., 1998; De Simone et
al., 1991; Lai et al., 1991). HNF1α associates with the
highly related HNF1β (vHNF1) to form homo- or hetero-
dimers (Wang et al., 1998). The expression of HNF1β
dominant negative form resulted in reduction of GLUT2
gene expression (Mendel et al., 1991). Mutation of HNF1β
resulted in decreased transcription of GLUT2 and was
ultimately related to familial type 2 diabetes mellitus
(Tomura et al., 1999). 
HNF3, a member of the forkhead winged helix family,
has been known to play a role in liver and gut develop-
ment (Lai et al., 1991). The HNF3 isotypes, namely,
HNF3α, 3β, and 3γ bind to the same DNA sequence
with different affinities. It was shown that HNF3 could
activate the albumin gene expression by repositioning
the nucleosomes in the albumin enhancer (McPherson
et al., 1993; Shim et al., 1998). 
Human GLUT2 promoter has binding sites for HNF1
and HNF1 and/or HNF3 at the −1030 bp region and +74
bp region, respectively (Tomura et al., 1999; Cha et al.,
2000). Whereas it is well known that HNF1 and HNF3
plays important roles in tissue-specific expression of
GLUT2, we do not know whether these transcription
factors are able to mediate tissue specific expression of
glucokinase which is mainly expressed in liver and
pancreatic β-cells.
In this study, we have identified the cis-elements for
HNF1 or HNF3 in the glucokinase gene promoters pre-
sent in liver and pancreatic β-cells. Based on these
results, we propose that the expression of GLUT2 or
glucokinase in the liver or pancreatic β-cells may be
governed by the action of HNF1 or HNF3 that are
predominant transcriptional factors of these tissues.
Materials and Methods
Construction of plasmids
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Rat glucokinase promoter spanning −1003/+196 of β cell
specific gene and −1448/+127 of liver specific gene
(Magnuson et al., 1989) were cloned into pGL3 basic
reporter vector (Promega, Madison, WI) and named
pRGP-1003 and pRGL-1448, respectively. The sequences
of constructs were confirmed by DNA sequencing.
pRSV-HNF1 and pRSV-vHNF1 were given by Dr. M.
Yaniv. pGem-HNF3α and pGem-HNF3β were kindly
provided by Dr. R.H. Costa.
Preparation of nuclear extracts
Nuclear extracts from liver of male Sprague-Dawley rats
or cell lines were prepared as described by Gorski et al.
(Gorski et al., 1986) or Dignam et al. (Dignam et al.,
1990). Protein concentration was determined according
to Bradford (Bradford et al., 1976). The extracts were
frozen in aliquots and stored at −70°C. 
Northern blot analysis 
Total RNA was extracted from various tissues and cell
lines using the TRIzol reagent (Life Technologies) follow-
ing the manufacturer’s protocol. Twenty micrograms of
total RNA was separated on 1% agarose gels contain-
ing 0.66 M formaldehyde. After electrophoresis, RNA
was transferred to a nylon membrane (Schleicher &
Schuell, Inc) by capillary transfer in the presence of 20x
SSC. Then the filter which was UV-crosslinked with UV-
crosslinker (Hoefer) was prehybridized and hybridized
with 32P-labeled HNF1α and HNF3β cDNA probes in
Rapid-hyb buffer (Amersham Life Science) at 58oC over-
night. After hybridization, the nylon membrane was rinsed
with 2x SSC, 0.1% SDS followed by 0.2x SSC, 0.1%
SDS and exposed to X-ray film at −70oC with an inten-
sifying screen.
Cell culture and transient transfection 
Cells used in this experiment were maintained as mono-
layer cultures and grown in appropriate media. Plasmid
DNAs were purified on Qiagen Midiprep kit columns
(Qiagen) at least twice independently. Cells were plated
in six-well tissue culture plates at a density of 1 × 106
cells/well in 2 ml of medium. After a 20-h attachment
period, transfections were performed with LipofectAMINE
PLUS reagent (Life Technologies, Inc), according to the
manufacturer’s protocol. Briefly, 0.5 µg of each construct
of GLUT2 promoter, 0.1 µg of pCMV-β-galactosidase
and 4 µl of plus reagent and 2 µl of lipofectamine in 200
µl of OPTI-MEM I (Life Technologies, Inc) media lacking
serum were mixed and added to cells. After 3 h, the
medium containing the lipofectamine-DNA complex was
removed and replaced by appropriate media (containing
serum and antibiotics). Cells were then cultured further
for 48 h and harvested in reporter lysis buffer (Promega).
The lysed cells were centrifuged to remove cell debris
and the supernatant was collected. Luciferase assays
were conducted with 10 µl of cell extracts and 50 µl of
luciferase assay reagent (Promega). β-Galactosidase
activity was determined with 10 µl of cell extract and 190
µl assay reagent containing O-nitrophenol-β-D-galacto-
pyranoside in a colorimetric assay. Luciferase data were
expressed as luciferase activity corrected by β-galacto-
sidase activity in the cell lysate. Each transfection was
performed in triplicate and repeated three to five times.
Electrophoretic mobility shift assay (EMSA) and
supershift assay
Probes for gel-shift assays were labeled with 32P in the
presence of [γ-32P]ATP and T4 polynucleotide kinase.
Labeled double-stranded oligonucleotides were prepared
by mixing five-molar amounts of the complementary
single-stranded DNAs in 50 mM NaCl, heating to 90oC
for 5 min and then cooling to room temperature. The
oligonucleotide used in these assays was as follows: 
RGP2, 5'-GGCAAAGCACTTATTGATTAGATTCCCATC-3'
The oligonucleotides for HNF1 (Vaulont et al., 1989) and
HNF3 (Costa et al., 1989) were synthesized, and Oct-1
(5'-TGTCGAATGCAAATCACTAGAA-3') was purchased
from Promega. The labeled probe (50,000 cpm) was
combined with nuclear proteins in 25 mM Tris/HCl, pH
7.4, 80 mM KCl, 0.1 mM EDTA, 1 mM DTT and 10% (v/
v) glycerol. The nonspecific competitor, 1.5 µg of poly
(dI-dC), was added to each binding reaction. Binding
reaction mixtures were incubated for 20 min on ice and
resolved on a non-denatured (5% w/v) acrylamide gel
(29 : 1 w/w acrylamide/bisacrylamide) in 0.5 × TBE at
4oC. For competition assays, 100-fold molar excess of
various unlabeled competitor DNAs were added to the
reaction mixture prior to the addition of the labeled probe.
The dried gels were exposed to X-ray film at −70°C with
an intensifying screen.
Statistical analysis
All transfection studies were performed in three to five
separate experiments, where triplicate dishes were trans-
fected. The data were represented as mean ± standard
deviation. Statistical analysis was carried out using
Microsoft Excel® (Microsoft). 
Results and Discussion
Northern blot analysis of the tissues or cell lines known
to express GLUT2 or GK (liver, H4IIE, HepG2, HIT-T15,
MIN6) showed abundant levels of HNF1 and HNF3
mRNA whereas their expressions were found to be low
in the cells or tissues where GLUT2 or GK expression
were low, i.e. brain, heart, NIH3T3, and HeLa (Jetton et
al., 1992; Miyazaki et al., 1990) (Figure 1). GLUT2 was
expressed only in renal proximal (convoluted) tubule of
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kidney (Kamran et al., 1997) and HNF1β, a major sub-
type of HNF1 in the kidney, was reported to suppress
transcriptional activities of many liver genes (Song et al.,
1998). Thus, the highly expressed HNF1β but not HNF3
could likely have caused repression of GLUT2 or GK
expression in the kidney. The northern blot results
showed that the expression of HNF1 and HNF3 was
correlated well with GLUT2 and GK levels in the tissues
or cell lines tested in this study (Figure 1). Search for the
consensus sequences for HNF1 or HNF3 in the GLUT2
or GK gene (Figure 2) showed that the promoter of
GLUT2 contains HNF1 and HNF3 consensus sequences
and they are well conserved in the human, mouse and
rat promoters (Cha et al., 2000). GK uses different pro-
moters in liver and pancreas (Magnuson et al., 1989),
but both of them contain many HNF3 binding sites.
In order to explore whether HNFs are major effectors
in tissue specific expression of GLUT2 or GK gene, the
promoter region of these genes amplified by polymer-
ase chain reaction (PCR) were linked to pGL3-lucifer-
ase vector and the effects of HNFs on the promoter
activities were observed in the cells used for northern
blot analysis (Figure 3). The high promoter activities of
GLUT2 in liver or pancreatic β cells was reported (Cha
et al., 2000). The pancreatic promoter of GK gene showed
high activities in the β cell lines, HIT-T15 and MIN6
(Figure 3a). The liver type GK promoter was activated in
HepG2 cells (Figure 3b). However, this promoter showed
minimal activities when the reporter constructs were
transfected into cells expressing minimal HNFs (Figure
1, 3a and 3b). 
To confirm experimentally whether such consensus
sequences predicted from the database search were
correct in its ability to bind HNF1 or HNF3, electropho-
retic mobility shift assay (EMSA) was carried out. An
oligonucleotide, covering the region between −14 and
+10 of rat pancreatic GK promoter (RGP2) synthesized
were used for the experiment. In RGP2 probe, one
HNF3 binding site was detected (Figure 4). The absence
of HNF1 consensus sequence on the GK promoter
supported the observation that HNF1 dominant negative
form couldn’t suppress the GK gene expression in the
beta cells (Wang et al., 1998). Cha et al. showed that
HNF1 and HNF3 could bind to the region between +87
and +132 of GLUT2 promoter. These data suggest that
the expression of GLUT2 or GK is associated with the
expression of HNF1 and/or HNF3 in the cells. And such
association has to be important factors in overall regu-
lation of GLUT2 or GK expression in the liver or pan-
creatic β cell along with the expected contributions and/
or interactions with other transcription factors.
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Figure 1. Northern blot analysis of HNF1 and HNF3 in variable tissues and
cell lines. Twenty µg of total RNA was separated on 1% agarose gels and
transfer onto a nylon membrane. The membrane was hybridized with 32P-
labeled HNF1α and HNF3β cDNA probes. G3PDH gene served as an
internal control for the different RNA samples. 
Figure 2. The consensus sequences for HNF1 and HNF3 in the human GLUT2, rat pancreatic glucokinase, and rat liver glucokinase promoters.
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